Drawing for BLOODSTREAM

USPTO serial 88401721

BLOODSTREAM

Reviewed by CopyMark Law Group

Reg. 5896714Status 705Registered
Filing date
Status date
Registration date
Oct 29, 2019
Examiner
KHAN, ASMAT A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with BLOODSTREAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly I. Boesche

Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP125 South Wacker Drive, Suite 2050CHICAGO, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
001[ Diagnostic reagents and nucleic acids for scientific and research use, namely, to screen donated blood and tissue samples to detect the presence of harmful viruses; Diagnostic reagents and nucleic acids for diagnostic laboratory use, namely, to screen donated blood and tissue samples to detect the presence of harmful viruses ]SECTION 8 - CANCELLED—
005[ Diagnostic reagents and nucleic acids for medical use, namely, to check, screen donated blood and tissue samples to detect the presence of harmful viruses ]SECTION 8 - CANCELLED—
009Diagnostic software for medical and diagnostics use, namely, to generate and manage testing results of donated blood and tissue samples to detect the presence of harmful viruses [ ; Laboratory instruments for diagnostics use, namely, to screen donated blood and tissue samples to detect the presence of harmful viruses; Laboratory instruments for diagnostics use, namely, to collect and pool donated blood and tissue samples to detect the presence of harmful viruses; Laboratory instruments for diagnostics use, namely, to dispense, add or combine assays to donated blood and tissue samples to detect the presence of harmful viruses ]ACTIVE—
010[ Medical diagnostic instruments for medical use, namely, for screening donated blood and tissue samples to detect the presence of harmful viruses; Medical diagnostic instrument for medical use, namely, for pooling donated blood and tissue samples to detect the presence of harmful viruses; Medical diagnostic instruments for medical use, namely, for dispensing, adding or combining assays to donated blood and tissue samples to detect the presence of harmful viruses ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 30, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 30, 2026C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 30, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 28, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Oct 29, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 29, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 13, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 13, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 3, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2019ALIEASSIGNED TO LIE—
Jun 19, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2019DOCKASSIGNED TO EXAMINER—
May 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance